← Return to Recommendation for second opinion on prostate MRI scan?

Discussion
Comment receiving replies
@rockin2047

I've read that mpMRI (Multiparametric MRI) has distinct advantages over standard MRI. The gold standard for an MRI machine is rated as a 3T (T=Tesla), but not sure if the mpMRI has the same designation. The following site says "Multiparametric (mp)-MRI has emerged as a robust method for localizing prostate tumors and determining their size, aggressiveness, and invasiveness, thereby improving disease detection, staging, and risk stratification (Hoeks et al., 2011)." https://sperlingprostatecenter.com/who-says-prostate-mri-is-too-expensive/ Then, another site states "What You Need to Know Before Reading Multiparametric MRI for Prostate Cancer" which really gets you into the technical weeds. However, the takeaway is that you need to find someone very experienced in interpreting the mpMRI scans. See https://www.ajronline.org/doi/full/10.2214/AJR.19.22751 A word about biopsy slide results. I read a comment from a J Hopkins pathologist who felt that some pathologists knowingly overstate what they see on the slide for fear of being sued. Regarding mpMRI scans, one could ask how many of these scans they perform in a year as an indication of their experience?? If you are on the East coast I found this large company that does scans, but only a few do mpMRI scans. See https://www.universityradiology.com/

Jump to this post


Replies to "I've read that mpMRI (Multiparametric MRI) has distinct advantages over standard MRI. The gold standard for..."

Thanks for information. Very helpful. I belong to three support groups (one local, the other two are online). They all stress the importance of second opinions because of the subjectivity involved and because of the reasons you mentioned above. Dr. Mark Scholtz, founder of the Prostate Cancer Research Institute and double board certified medical oncologist has an excellent series on seeking opinions from radiologists who are experienced in reading prostate MRIs before making a decision on treatment.